» Articles » PMID: 36004540

Understanding How Pregnancy Protects Against Ovarian and Endometrial Cancer Development: Fetal Antigens May Be Involved

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2022 Aug 25
PMID 36004540
Authors
Affiliations
Soon will be listed here.
Abstract

It is well known that many factors, including infertility, obesity, type 2 diabetes, and family history of cancer, increase the risk of developing endometrial and ovarian cancer. However, multiparous women are known to have a lower risk of developing either ovarian or endometrial cancer than nonparous women. The lack of ovulation and shifting of sex hormonal balance, with decreased estrogen levels and increased progesterone levels during pregnancy, has traditionally been thought to be the major contributor to this decreased risk. However, in reality, the mechanisms underlying this phenomenon are relatively unknown. Increasing evidence suggests that endocrine factors are unlikely to completely explain the protective effect of pregnancies, and that multiple other nonendocrine mechanisms including fetal antigens and the newly proposed dormant cells hypothesis may also be involved. In this review, we summarize recent evidence and describe the potential underlying mechanisms that may explain how pregnancy protects against the development of ovarian and endometrial cancers in women's later life.

Citing Articles

Ovarian Dysgerminoma Associated With Pregnancy Presenting as Hemoperitoneum: An Obstetric Case Report.

Gbary-Lagaud E, Loba J, Kouakou-Kouraogo R, Houphouet-Mwandji C, Adjoby R Clin Case Rep. 2025; 13(2):e70203.

PMID: 39959557 PMC: 11828663. DOI: 10.1002/ccr3.70203.


Association of Pregnancy Complications with Endometrial or Ovarian or Breast Cancer: A Case Control Study.

Han L, Leung H, Lin H, Leung J, Chan A Medicina (Kaunas). 2025; 61(1).

PMID: 39858983 PMC: 11766899. DOI: 10.3390/medicina61010001.


The clinicopathological role of miRNA-196a and its SNP variant rs11614913 in high-grade ovarian cancer.

Lesniak E, Stec-Martyna E, Domanska-Senderowska D, Romanowicz H, Krawczyk T, Bienkiewicz J Prz Menopauzalny. 2025; 23(4):180-184.

PMID: 39811383 PMC: 11726191. DOI: 10.5114/pm.2024.145949.


Endometrial cancer and simultaneous pregnancy, an unusual combination. Case report.

Vanesa D, Lucia S, Mar R, Jesus C J Obstet Gynaecol Res. 2024; 51(1):e16147.

PMID: 39513540 PMC: 11635182. DOI: 10.1111/jog.16147.

References
1.
Chen Q, Rutten V, Cheng W, Tong M, Wei J, Stone P . Phagocytosis of Extracellular Vesicles Extruded From the Placenta by Ovarian Cancer Cells Inhibits Growth of the Cancer Cells. Int J Gynecol Cancer. 2017; 28(3):545-552. DOI: 10.1097/IGC.0000000000001140. View

2.
Pike M, Pearce C, Wu A . Prevention of cancers of the breast, endometrium and ovary. Oncogene. 2004; 23(38):6379-91. DOI: 10.1038/sj.onc.1207899. View

3.
Maccio A, Madeddu C . Inflammation and ovarian cancer. Cytokine. 2012; 58(2):133-47. DOI: 10.1016/j.cyto.2012.01.015. View

4.
Janerich D . The fetal antigen hypothesis for breast cancer, revisited. Med Hypotheses. 1994; 43(2):105-10. DOI: 10.1016/0306-9877(94)90059-0. View

5.
Schock H, Zeleniuch-Jacquotte A, Lundin E, Grankvist K, Lakso H, Idahl A . Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study. BMC Pregnancy Childbirth. 2016; 16(1):146. PMC: 4932669. DOI: 10.1186/s12884-016-0937-5. View